Startup based in the United States, most recent round Acquired.
Aimmune Therapeutics is a company headquartered in the United States. Aimmune Therapeutics has been acquired.
Aimmune Therapeutics develops treatments for food allergies aimed at reducing allergic reactions and improving patient quality of life.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.